Balyasny Asset Management’s AMN Healthcare AMN Stock Holding History

Balyasny Asset Management’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-108,500	Closed	-$4.96M	–	2034
2017 Q3	$4.96M	Buy	+108,500	New	+$4.15M	0.02%	723

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Balyasny Asset Management's AMN Position: Q2 2026 in Review

Balyasny Asset Management sold out of AMN Healthcare (AMN) in Q2 2026, closing a stake of 69,686 shares — an estimated $1.28M sold.

Balyasny Asset Management first reported a position in AMN in Q2 2017 and held it in 25 quarters. The position peaked at $22.7M in Q3 2021. 285 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

Balyasny Asset Management reported no remaining AMN Healthcare position as of Q2 2026 after selling out during the quarter.
Balyasny Asset Management sold 69,686 AMN Healthcare shares in Q2 2026, an estimated $1.28M.
Balyasny Asset Management first reported a position in AMN Healthcare in Q2 2017 and held it in 25 quarters.
Balyasny Asset Management's AMN Healthcare position peaked at $22.7M in Q3 2021.
285 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.